Health & Environmental Research Online (HERO)


Print Feedback Export to File
3981309 
Journal Article 
Use of high-throughput in vitro toxicity screening data in cancer hazard evaluations by IARC Monograph Working Groups 
Chiu, WA; Guyton, KZ; Martin, MT; Reif, DM; Rusyn, I 
2018 
Yes 
ALTEX
ISSN: 1868-596X
EISSN: 1868-8551 
35 
51-64 
English 
Evidence regarding carcinogenic mechanisms serves a critical role in International Agency for Research on Cancer (IARC) Monograph evaluations. Three recent IARC Working Groups pioneered inclusion of the US Environmental Protection Agency (EPA) ToxCast program high-throughput screening (HTS) data to supplement other mechanistic evidence. In Monograph V110, HTS profiles were compared between perfluorooctanoic acid (PFOA) and prototypical activators across multiple nuclear receptors. For Monograph V112 -113, HTS assays were mapped to 10 key characteristics of carcinogens identified by an IARC expert group, and systematically considered as an additional mechanistic data stream. Both individual assay results and ToxPi-based rankings informed mechanistic evaluations. Activation of multiple nuclear receptors in HTS assays showed that PFOA targets peroxisome proliferator activated and other receptors. ToxCast assays substantially covered 5 of 10 key characteristics, corroborating literature evidence of "induces oxidative stress" and "alters cell proliferation, cell death or nutrient supply" and filling gaps for "modulates receptor-mediated effects." Thus, ToxCast HTS data were useful both in evaluating specific mechanistic hypotheses and in the overall evaluation of mechanistic evidence. However, additional HTS assays are needed to provide more comprehensive coverage of the 10 key characteristics of carcinogens that form the basis of current IARC mechanistic evaluations. 
carcinogenicity; high throughput screening; in vitro; mechanisms 
PFAS
• Additional PFAS (formerly XAgency)
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFOA (335-67-1) and PFOS (1763-23-1)
          Literature Search – Adverse outcome pathway (2015-present)
               Pubmed
• PFAS 150
     Literature Search August 2019
          PubMed
          Web of Science
     Not prioritized for screening
     Ammonium perfluorooctanoate
     Perfluorooctanoic acid
• PFBA
     Protocol References
• PFNA
     Litsearch Update 2017-2018
          Pubmed
          Toxline
     Literature Search
          Pubmed
          Toxline
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search – Adverse outcome pathway (2015-present)
          Pubmed
     Screening Results
          In vitro/ex vivo/in silico
               Receptor activation
               Peroxisomal proliferation
               Other mechanistic studies
     Literature Search Update (2013-2019)
          PubMed
          WOS